[11C]PIB binding in Parkinson's disease dementia.
Walter Maetzler1, Matthias Reimold, Inga Liepelt
1Hertie Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Neuroimage
|November 24, 2007
Summary
[(11)C]PIB Positron Emission Tomography (PET) scans can differentiate Parkinson's disease with dementia (PDD) by detecting amyloid and alpha-synuclein protein deposits in the brain, aiding in diagnosis.
Area of Science:
- Neuroimaging
- Neuropathology
- Molecular Biology
Background:
- [(11)C]PIB PET imaging visualizes amyloid-beta plaques, a hallmark of Alzheimer's disease (AD).
- Parkinson's disease with dementia (PDD) involves Lewy bodies, primarily alpha-synuclein, raising questions about PIB binding in PDD.
- Investigating PIB binding in PDD could clarify its diagnostic utility for proteinopathies.
Purpose of the Study:
- To determine if [(11)C]PIB-PET can detect specific amyloid binding in PDD patients.
- To assess if PIB binding in PDD reflects fibrillar alpha-synuclein accumulation.
- To differentiate PDD from AD and controls using PIB-PET.
Main Methods:
- 10 PDD patients underwent [(11)C]PIB-PET scans, compared with 11 controls and 6 AD patients.
- Postmortem brainstem sections from Parkinson's disease (PD) and PDD patients were stained with PIB.
- Histological PIB distribution was evaluated in brainstem sections to correlate with PET findings.
Main Results:
- Only 2 PDD patients showed cortical PIB binding similar to AD patients.
- 8 PDD patients exhibited control-like cortical binding but elevated PIB uptake in the pons and mesencephalon.
- Histology confirmed PIB binding to Lewy bodies and neuromelanin in PD/PDD brainstems, not in controls.
Conclusions:
- [(11)C]PIB-PET may help distinguish PDD cases with cortical amyloid.
- Elevated PIB uptake in the brainstem of PDD patients could indicate alpha-synuclein accumulation.
- PIB-PET offers potential for differentiating PDD subtypes and understanding its underlying pathology.
More Related Videos
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...